Terence M. Berge - Apr 28, 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Role
VP-Corporate Controller
Signature
/s/ Daniel S. Jonas for Terence M. Berge by Power of Attorney
Stock symbol
CNMD
Transactions as of
Apr 28, 2023
Transactions value $
-$1,005,316
Form type
4
Date filed
5/2/2023, 04:12 PM
Previous filing
Mar 3, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $117K +2.8K +278.88% $41.93 3.8K Apr 28, 2023 Direct
transaction CNMD Common Stock Options Exercise $324K +5.4K +141.96% $59.96 9.2K Apr 28, 2023 Direct
transaction CNMD Common Stock Options Exercise $425K +5.4K +58.67% $78.76 14.6K Apr 28, 2023 Direct
transaction CNMD Common Stock Options Exercise $498K +5.1K +34.92% $97.69 19.7K Apr 28, 2023 Direct
transaction CNMD Common Stock Sale -$357K -2.8K -14.21% $127.44 16.9K Apr 28, 2023 Direct F1
transaction CNMD Common Stock Sale -$685K -5.4K -31.95% $126.78 11.5K Apr 28, 2023 Direct F2
transaction CNMD Common Stock Sale -$683K -5.4K -46.94% $126.42 6.1K Apr 28, 2023 Direct
transaction CNMD Common Stock Sale -$646K -5.1K -83.55% $126.65 1K Apr 28, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -2.8K -100% $0.00* 0 Apr 28, 2023 Common Stock 2.8K $41.93 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5.4K -100% $0.00* 0 Apr 28, 2023 Common Stock 5.4K $59.96 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5.4K -66.67% $0.00 2.7K Apr 28, 2023 Common Stock 5.4K $78.76 Direct F5
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5.1K -50% $0.00 5.1K Apr 28, 2023 Common Stock 5.1K $97.69 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.25 to $127.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.60 to $127.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.54 to $126.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period